| Filed On | Filing |
|---|---|
| 01 Apr 2026 |
Form 3: Levy Elliott M., Director
Holds 13 shares of Ordinary Shares |
| 24 Mar 2026 | Form 3: Harrison David James, Head of Translational Medicine |
| 20 Mar 2026 |
Form 3: Mellish Martin C.b., Director
Holds 28 shares of Ordinary Shares |
| 19 Mar 2026 |
Form 3: Bloss Jeffrey D., Chief Medical Officer
Holds 47,136 shares of Ordinary Shares |
| 18 Mar 2026 | Form 3: Webster Ian Alexander, See Remarks |
| 18 Mar 2026 | Form 3: Kay Andrew Martin, Director |
| 18 Mar 2026 | Form 3: Leperlier Cyrille, Director |
| 18 Mar 2026 | Form 3: Bruce Theresa Margaret Ms, Chief Operating Officer |
| 18 Mar 2026 |
Form 3: Griffith Hugh, Director
Holds 1,000,000 shares of Ordinary Shares |
Loading...
